Clinical Trial Update: Clofarabine in Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update shows results for clofarabine in chronic lymphocytic leukemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Clolar (Clofarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematologic Neoplasms, Lymphoproliferative Disorders | Phase 1 | Status: COMPLETED